TSLA vs WKSP

Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.

WKSP exhibits critical financial weakness, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental distress. While the company shows impressive top-line revenue growth of 62% YoY and maintains a healthy current ratio of 2.50, these are overshadowed by a catastrophic profit margin of -120.19% and a 5-year price collapse of 98.2%. The stock trades at a significant discount to book value (P/B 0.47), but the lack of a Graham Number or positive earnings makes it a highly speculative micro-cap play. Despite an optimistic analyst target of $7.00, the deterministic health scores suggest a high risk of continued capital erosion.